Leonard Schaeffer Joins Amgen's Board of Directors
THOUSAND OAKS, Calif., March 9 -- Amgen Inc.
(Nasdaq: AMGN), the world's largest biotechnology company, today announced
that it has appointed Leonard D. Schaeffer to its board of directors.
Schaeffer is chairman and chief executive officer of WellPoint Health Networks
Inc., (NYSE: WLP) the nation's second largest healthcare insurer.
"With his wealth of healthcare experience in both the corporate and
government sectors, Leonard Schaeffer brings to Amgen's board of directors
background and insights that will help solidify our position as the world's
leading biotech company," said Kevin Sharer, Amgen's chairman and chief
Named President and CEO of Blue Cross of California in 1986, Schaeffer is
credited with converting the company to a for-profit status, creating
WellPoint in 1993, which now has a market capitalization over more than
Schaeffer has served in the federal government as Administrator of the
Health Care Financing Administration (HCFA), now Centers for Medicare and
Medicaid Services (CMS), and Assistant Secretary for Management and Budget of
the Department of Health and Human Services. He also serves on the boards of
directors of Allergan, Inc., Blue Cross and Blue Shield Association, The
Coalition for Affordable and Quality Healthcare, American Association of
Health Plans, Health Insurance Association of America, National Institute for
Health Care Management, National Health Foundation and Council on Health Care
Economics and Policy. Schaeffer also co-chairs the Advisory Council of
Harvard Medical School's Department of Healthcare Policy, is a member of the
Advisory Council of Princeton University's Department of Economics and a
member of the Board of Councilors of the University of Southern California's
School of Policy, Planning, and Development.
Amgen is a global biotechnology company that discovers, develops,
manufactures and markets important human therapeutics based on advances in
cellular and molecular biology.
Amgen, Thousand Oaks
Mary Klem, (805) 447-4587 (media)
Cary Rosansky, (805) 447-1060 (investors)